drugset / Trial / NCT03890133

Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia

NCT03890133

RandomizedParallel-groupSingle-blindBasic science

Summary

Fibromyalgia (FM) is a chronic debilitating musculoskeletal pain syndrome. "Central sensitization" is an important mechanism of the disease. Recent studies have shown that "microbiome-gut-brain axis" imbalance may be one of the important mechanisms of "central sensitization". The purpose of this study was to investigate the therapeutic mechanism of Ba-Duan-Jin therapy in the treatment of fibromyalgia by improving intestinal microecology. The mechanism was evaluated by comparing the results of brain functional MRI (fMRI) and microbacterial analysis of the patients' stool pre and post treatment .

Timeline

Start
2019-04-01
Primary completion
2022-05-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg
Comparator Pregabalin Small molecule 300 mg

Indications